Cases & Deals

Concateno acquires Medscreen Holdings

Clients Concateno plc

Jones Day advised Concateno plc, a leading drug and alcohol testing provider and a manufacturer of clinical diagnostic products, in connection with its acquisition of Medscreen Holdings Limited, a global provider of drugs and alcohol testing services. The acquisition, which constituted a reverse takeover, was funded through a combination of a placing to raise £18.7 million ($37 million), new debt facilities and existing cash resources. The total consideration was £30 million ($60 million).

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.